Role of superoxide dismutase in in vivo and in vitro nitrate tolerance

British Journal of Pharmacology

Volumn 127, Issue 5, 1999, Pages 1224-1230

  Münzel, Thomas ^d   Hink, Ulrich ^b   Yigit, Hussein ^b   Macharzina, Roland ^b   Harrison, David G ^a   Mülsch, Alexander ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

CuZn superoxide dismutase; Diethyldithiocarbamate; Glycerol trinitrate; NADH oxidase; Nitrate tolerance; Rabbit aorta; Superoxide anion radical; Tiron

Indexed keywords

ACETYLCHOLINE; COPPER ZINC SUPEROXIDE DISMUTASE; DIETHYLTHIOCARBAMATE; GLYCERYL TRINITRATE; NITRATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TIRON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; FEMALE; MALE; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ACETYLCHOLINE; ANIMALS; BLOOD VESSELS; DITIOCARB; DRUG TOLERANCE; FEMALE; MALE; MULTIENZYME COMPLEXES; NADH, NADPH OXIDOREDUCTASES; NITROGLYCERIN; RABBITS; SUPEROXIDE DISMUTASE; SUPEROXIDES; TIRON; VASODILATION;

EID: 0032808109     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702622     Document Type: Article

References (22)

1. AXELSSON, K.L. & ANDERSSON, R.G. (1983). Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. Eur. J. Pharmacol., 88, 71-79.
2. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
3. CLANCY, R.M., LESZCZYNSKA-PIZIAK, J. & ABRAMSON, S.B. (1992). Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest., 90, 1116-1121.
4. ELKAYAM, U., MEHRA, A., SHOTAN, A. & OSTRZEGA, E. (1992). Nitrate resistance and tolerance: potential limitations in the treatment of congestive heart failure. Am. J. Cardiol., 70, 98B-104B.
5. FAM, W.M. & MCGREGOR, M. (1968). Effect of nitroglycerin and dipyridamole on regional coronary resistance. Circ. Res., 22, 649-659.
6. FUKUI, T., ISHIZAKA, N., RAJAGOPALAN, S., LAURSEN, J.B., CAPERS IV. Q., TAYLER, W.R., HARRISON, D.G., DE LEON, H., WILCOX, J.N. & GRIENDLING, K.K. (1997). p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ. Res., 80, 45-51.
7. INOUE, N., RAMASAMY, S., FUKAI, T., NEREM, R.M. & HARRISON, D.G. (1996). Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ. Res., 79, 32-37.
8. KEITH, R.A., BURKMAN, A.M., SOKOLOSKI, T.D. & FERTEL, R.H. (1982). Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J. Pharmacol. Exp. Ther., 221, 525-531.
9. KURZ, S., HINK, U., NICKENIG, G., BORTHAYRE, A.B., HARRISON, D.G. & MUNZEL, T. (1999). A role for angiotensin II in nitrate tolerance: chronic AT-1 receptor blockade prevents development of tolerance and cross tolerance. Circulation, (in press).
10. MOLINA, C.R., ANDRESEN, J.W., RAPOPORT, R.M., WALDMAN, S. & MURAD, F. (1987). Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta. J. Cardiovasc. Pharmacol., 10, 371-378.
11. MÜNZEL, T., HEITZER, T., KURZ, S., HARRISON, D.G., LUHMAN, C., PAPE, L., OLSCHEWSKI, M. & JUST, H. (1996a). Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease. J. Am. Coll. Cardiol., 27, 297-303.
12. MÜNZEL, T., KURZ, S., RAJAGOPALAN, S., TARPEY, M., FREEMAN, B. & HARRISON, D.G. (1995a). Identification of the membrane bound NADH oxidase as the major source of superoxide anion in nitrate tolerance. Endothelium, 3 (suppl.), s14(abstract).
13. MÜNZEL, I., KURZ, S., RAJAGOPALAN, S., THOENES, M., BERRINGTON, W.R., THOMPSON, J.A., FREEMAN, B.A. & HARRISON, D.G. (1996b). Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug. J. Clin. Invest., 98, 1465-1470.
14. MUNZEL, T., SAYEGH, H., FREEMAN, B.A., TARPEY, M.M. & HARRISON, D.G. (1995b). Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest., 95, 187-194.
15. NEEDLEMAN, P. (1970). Tolerance to the vascular effects of glyceryl trinitrate. J. Pharmacol. Exper. Therap., 171, 98-102.
16. NEEDLEMAN, P., JAKSCHIK, B. & JOHNSON JR, E. (1973). Sulfhydryl requirement for relaxation of vascular smooth muscle. J. Pharmacol. Exper. Therap., 187, 324-331.
17. NEEDLEMAN, P. & JOHNSON, E.M.J. (1973). Mechanism of tolerance development to organic nitrates. J. Pharmacol. Exper. Therap., 184, 709-715.
18. PACKER, M., LEE, W., KESSLER, P.D., GOTTLIEB, S.S., MEDINA, N. & YUSHAK, M. (1987). Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N. Engl. J. Med., 317, 799-804.
19. RAJAGOPALAN, S., KURZ, S., MÜNZEL, T., TARPEY, M., FREEMAN, B.A., GRIENDLING, K.K. & HARRISON, D.G. (1996). Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest., 97, 1916-1923.
20. ROTH, A., KULICK, D., FREIDENBERGER, L., HONG, R., RAHLMTOOLA, S.H. & ELKAYAM, U. (1987). Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure. J. Am. Coll. Cardiol., 9, 858-864.
21. SELLKE, F.W., MYERS, P.R., BATES, J.N. & HARRISON, D.G. (1990). Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin. Am. J. Physiol., 258, H515-H520.
22. SELLKE, F.W., TOMANEK, R.J. & HARRISON, D.G. (1991). L-cysteine selectively potentiates nitroglycerin-induced dilation of small coronary microvessels. J. Pharmacol. Exp. Ther., 258, 365-369.